Prochlorperazine Maleate 3 mg Buccal 8 Tablets contain 3 mg of prochlorperazine maleate per buccal tablet. They are used for the symptomatic relief of nausea and vomiting caused by previously diagnosed migraine.

The tablets are designed for buccal administration. They are placed high up along the top gum under the upper lip, where they soften, adhere to the gum and gradually dissolve. They should not be chewed or swallowed whole.

The recommended dose for 18 years and over is one or two tablets twice daily for a maximum of 2 days.

Patient Information Leaflet

Main ingredient: Prochlorperazine maleate 3 mg per buccal tablet. Excipients: compressible sugar (sucrose), xanthan gum, locust bean gum, riboflavin 5-phosphate sodium, povidone K30, talc, magnesium stearate.

Prochlorperazine Maleate 3 mg Buccal Tablets are used for nausea and vomiting caused by previously diagnosed migraine.

Adults (18y +): Use one or two tablets twice daily. This corresponds to a maximum of four tablets, or 12 mg of prochlorperazine maleate, in 24 hours when used according to the stated dosing schedule.

Place the tablet high up along the top gum, under the upper lip, on either side of the mouth. Do not swallow the tablet whole or chew it.

Allow the tablet to soften, adhere to the gum and dissolve slowly and completely. This may take around 1 to 2 hours. Avoid moving the tablet around the mouth with your tongue, as this may make it dissolve too quickly.

If you wear dentures, the tablet may be placed in a comfortable position between the lip and gum.

The tablets are best used after meals.

If you forget a dose, do not use a double dose to make up for it. Continue with the next dose as directed.

If you accidentally use too many tablets, seek medical attention immediately and take any remaining medicine or the empty packaging with you.

Do not use Prochlorperazine Maleate 3 mg Buccal Tablets if you:

• Are allergic to prochlorperazine maleate or any of the other ingredients.
• Have impaired liver function.
• Have existing blood disorders.
• Have epilepsy.
• Have Parkinson's disease.
• Have narrow-angle glaucoma.
• Have problems caused by an enlarged prostate.

Speak to a doctor before using this medicine if you are elderly, have heart disease, have previously had a heart attack, have a prolonged QT interval or a family history of prolonged QT interval, have low potassium or magnesium levels, have risk factors for stroke or blood clots, have myasthenia gravis, or have AIDS.

Prochlorperazine can increase sensitivity to sunlight. Avoid excessive direct sunlight and use suitable sun protection while using the medicine.

Tell your doctor or pharmacist about other medicines you are taking. Important interactions may occur with medicines that affect heart rhythm, certain antibiotics, sedatives and tranquillisers, medicines for high blood pressure, anticholinergic medicines, anticonvulsants, lithium, desferrioxamine, oral anticoagulants and levodopa.

Do not drink alcohol while using Prochlorperazine, as alcohol may increase its effects on the central nervous system.

Pregnancy: Do not use this medicine if you are pregnant, might be pregnant or think you may be pregnant unless specifically advised otherwise by a doctor.

Breastfeeding: Do not use this medicine while breastfeeding or if you are planning to breastfeed.

Prochlorperazine can cause drowsiness. Avoid driving or using dangerous machinery until you know how the medicine affects you.

The tablets contain sucrose. If you have been told that you have an intolerance to certain sugars, speak to your doctor before using the medicine.

Stop using the medicine and seek immediate medical advice if you develop symptoms of a serious allergic reaction, unexplained high temperature with muscle stiffness or altered alertness, seizures, signs of a serious infection, abnormal or forceful heartbeats with breathing difficulties, symptoms of a blood clot, or symptoms associated with a severe fall in blood sodium.

If too many tablets are used accidentally, seek medical attention immediately.